Is A Fall Imminent For Merck Stock After A 12% Rise In A Month?
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Merck stock (NYSE: MRK) is up 12% in a month, outperforming the broader S&P500 index, up 5%. The rise in MRK stock can be attributed to the upbeat Q3 earnings it reported in late October. Its top and bottom line were well above our estimates, driven by market share gai
:max_bytes(150000):strip_icc():format(jpeg)/socialsecurity-whentoapply-794e7d2e1615450a9c7530288e2f5dad.jpg "Unlocking Benefits: The Best Time to Apply for Social Security")
:max_bytes(150000):strip_icc():format(jpeg)/creditscorecheck-c254d4f39aae46919b846f0f391011c6.jpg "Watch Out for These Top Internet Scams")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-685011611-3857c64421274483b5cc2ee96db5b57e.jpg "How to Choose a Credit Repair Company")
:max_bytes(150000):strip_icc():format(jpeg)/globaltrade-8e91fb7b1b8047988ef6b7acb0280bf5.png "International (Global) Trade: Definition, Benefits, and Criticisms")
:max_bytes(150000):strip_icc():format(jpeg)/Mediation-56a260535f9b58b7d0c975bb.jpg "How Divorce Impacts Your Credit Score")